Leadership, Planning and Evaluation

Sloan-Kettering Inst Can Research, New York NY

Investigators

Linked publications, trials & patents

Abstract

ABSTRACT Eight individuals serve as Senior Leaders of the Memorial Sloan Kettering Cancer Center (MSK). Selwyn M. Vickers, MD, FACS, MSK’s President and Chief Executive Officer, is the Director of this NCI-supported Comprehensive Cancer Center. Physician-scientist Dr. Charles Rudin, MD, PhD serves as the Deputy Director of the Cancer Center. Dr. Vickers works with MSK’s Board of Governing Trustees to provide stable governance and financial oversight of MSK, and together with Dr. Rudin and Anaeze Offodile II, MD, MPH, MSK’s Chief Strategy Officer, Dr. Vickers sets the strategic vision for the Cancer Center, ensuring that the cancer-focused mission of the Center is relevant to the Center’s catchment area and fosters outreach to its population. Lisa DeAngelis, MD is MSK’s Chief Physician Executive; in this role, Dr. DeAngelis oversees and guides all human subjects research, primarily conducted within the clinical and population-based research programs, and sets standards for the infrastructure to support the clinical research review and monitoring, and data management. She also ensures that training for clinicians and biomedical professionals meets the highest standards. Joan Massagué, PhD is MSK’s Chief Scientific Officer and the Director of the Sloan Kettering Institute. In his role he oversees the non-clinical research programs and establishes standards for recruitment and retention of outstanding laboratory-based scientists. Dr. Massagué oversees the core facilities of the Center and manages the research budget to provide cutting-edge scientific support for the Center members. He also oversees the training programs for pre- and postgraduate laboratory researchers. Colin Begg, PhD is Associate Director for Population Sciences; Paul Sabbatini, MD is Associate Director for Clinical Research; Christine Iacobuzio- Donahue, MD, PhD, is Associate Director for Translational Science; and Luis Parada, PhD is Associate Director for Basic Science. The Associate Directors facilitate transdisciplinary research among the basic, bridge, clinical and population science programs and provide a conduit for bottom-up communication from the Program Leaders/Members to the Senior Leadership team. In overseeing the Cancer Center activities, the Senior Leadership relies on the counsel of outside advisors, represented by its Board of Scientific Consultants (BSC), the guidance of its Board of Governing Trustees, as well as many internal planning processes to support the planning and evaluation of the research programs and core facilities at the Center. MSK has used the guidance it has received to develop and execute its initiatives for research, clinical expansion, and community engagement. During the past six years, the BSC has reviewed the research in the programs as well as MSK’s Community Outreach and Engagement and scientific education and training (CRCE) programming. BSC members review with Senior Leadership evolving technologies that support cancer research and advise on core service offerings. The BSC has also reviewed newly recruited investigators and the training programs that bring outstanding students to MSK’s laboratories. The recommendations made by the BSC and other planning groups have led to strategic program planning, new faculty recruitments, shared resource development, and facility expansions.